Cardiac Vascular Reconstruction DynaCT for TAVI Procedures (CAVAREC)
Primary Purpose
Aortic Valve Disease
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
CAVAREC Image Processing algorithm
Sponsored by
About this trial
This is an interventional diagnostic trial for Aortic Valve Disease
Eligibility Criteria
Inclusion Criteria:
- Patients may either be scheduled for a TAVI procedure or scheduled for a cath lab appointment at any time after a TAVI procedure, or scheduled for device implant to treat congenital or structural heart disease.
Exclusion Criteria:
- Patient enrolled in research protocol with exclusions from simultaneous participation in another protocol
- Lack of research consent.
Sites / Locations
- Mayo Clinic
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
CAVAREC images
Arm Description
CAVAREC images from x-ray angiography
Outcomes
Primary Outcome Measures
Number of images of the aortic valve that are accurate
Qualitative image assessment will be performed by Board Certified Cardiologists and/or Radiologists who are familiar with cardiac CT image manipulation and interpretation.
Secondary Outcome Measures
Full Information
NCT ID
NCT02031796
First Posted
January 7, 2014
Last Updated
January 4, 2019
Sponsor
Mayo Clinic
Collaborators
Siemens Medical Solutions USA - CSG
1. Study Identification
Unique Protocol Identification Number
NCT02031796
Brief Title
Cardiac Vascular Reconstruction DynaCT for TAVI Procedures
Acronym
CAVAREC
Official Title
Cardiac Vascular Reconstruction (CAVAREC) DynaCT for 3D Assessment of Aortic Valve During TAVI Procedures
Study Type
Interventional
2. Study Status
Record Verification Date
January 2016
Overall Recruitment Status
Completed
Study Start Date
February 2014 (undefined)
Primary Completion Date
October 13, 2017 (Actual)
Study Completion Date
October 17, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mayo Clinic
Collaborators
Siemens Medical Solutions USA - CSG
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this work is to evaluate the feasibility of a new Cardiac Vascular Reconstruction (CAVAREC, Siemens Medical Systems, Germany) image reconstruction algorithm for use during transcatheter aortic valve implant (TAVI) procedures or interventional procedures to treat congenital or structural heart disease. CAVAREC utilizes the same x-ray projection images as currently acquired for clinical DynaCT. X-ray image acquisition to allow CAVAREC will occur during the interventional procedure after the TAVI device, other valve, or stent is implanted. If the participants already have a surgically-implanted TAVI device, stent or other device, and are having a cardiac catheterization, then an extra set of images will be acquired after your clinical care is complete, but before you leave the procedure room. The CAVAREC image processing algorithm will be implemented on an off-line workstation after the interventional procedure is complete. After the TAVI procedure, CAVAREC images will be quantitatively and qualitatively compared to Siemens DynaCT and cardiac CT images from Radiology. The results of this study will be used to direct further development of CAVAREC toward the end goal of providing improved imaging capabilities to guide TAVI, congenital heart, or structural heart treatment procedures.
Detailed Description
Compare utility of CAVAREC to standard DynaCT and cardiac CT for clinical assessment of the aortic valve and relevant, nearby anatomical structures.
Investigate the utility of CAVAREC to assess calcification within and surrounding the native aortic valve.
Investigate the utility of CAVAREC to assess procedural success, including prosthetic valve placement and annular anatomic correlates of paravalvular leak.
Validate utility of CAVAREC for images acquired during normal sinus rhythm.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aortic Valve Disease
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
35 (Actual)
8. Arms, Groups, and Interventions
Arm Title
CAVAREC images
Arm Type
Experimental
Arm Description
CAVAREC images from x-ray angiography
Intervention Type
Other
Intervention Name(s)
CAVAREC Image Processing algorithm
Intervention Description
After deployment of the TAVI prosthesis, other trans catheter valve, or stent, but before the patient care episode is completed, a set of rotational x-ray angiography images will be acquired and reconstructed using the clinical DyanCT and research CAVAREC algorithms.
Primary Outcome Measure Information:
Title
Number of images of the aortic valve that are accurate
Description
Qualitative image assessment will be performed by Board Certified Cardiologists and/or Radiologists who are familiar with cardiac CT image manipulation and interpretation.
Time Frame
approx 2 hours after surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients may either be scheduled for a TAVI procedure or scheduled for a cath lab appointment at any time after a TAVI procedure, or scheduled for device implant to treat congenital or structural heart disease.
Exclusion Criteria:
Patient enrolled in research protocol with exclusions from simultaneous participation in another protocol
Lack of research consent.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kenneth Fetterly, Ph.D.
Organizational Affiliation
Mayo Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mayo Clinic
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55905
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Cardiac Vascular Reconstruction DynaCT for TAVI Procedures
We'll reach out to this number within 24 hrs